Laidlaw Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Laidlaw Wealth Management's MDT Position: Q3 2023 in Review
Laidlaw Wealth Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,668 shares — an estimated $235K sold.
Laidlaw Wealth Management first reported a position in MDT in Q4 2019 and held it in 15 quarters. The position peaked at $905K in Q2 2021. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.
- Laidlaw Wealth Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
- Laidlaw Wealth Management sold 2,668 Medtronic shares in Q3 2023, an estimated $235K.
- Laidlaw Wealth Management first reported a position in Medtronic in Q4 2019 and held it in 15 quarters.
- Laidlaw Wealth Management's Medtronic position peaked at $905K in Q2 2021.
- 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.
Based on Laidlaw Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.